紫杉醇诱导的系统性硬化症一例
摘要
一例乳腺癌术后患者,使用表柔比星和紫杉醇化疗10个月后出现皮肤硬化改变,受累皮肤范同符合弥漫型系统性硬化症的特征,经过系统评估未发现内脏器官受累的证据。紫杉烷诱导发生硬皮病比较常见,多数患者自身抗体阴性,无内脏器官受累。
出处
《中华全科医师杂志》
2014年第1期77-77,共1页
Chinese Journal of General Practitioners
参考文献9
-
1Farrant PB,Mortimer PS,Gore M. Scleroderma and the taxanes.Is there really a link[J].{H}CLINICAL AND EXPERIMENTAL DERMATOLOGY,2004.360-362.
-
2Itoh M,Yanaba K,Kobayashi T. Taxane-induced scleroderma[J].{H}British Journal of Dermatology,2007.363-367.
-
3Takahashi T,Asano Y,Ichimura Y. A case of taxaneinduced scleroderma:a different expression profile of Fli1 proteins in dermal fibroblasts and microvascular endothelial cells compared with systemic sclerosis[J].{H}British Journal of Dermatology,2011.1393-1395.
-
4Hassett G,Harnett P,Manolios N. Scleroderma in association with the use of docetaxel (taxotere) for breast cancer[J].{H}Clinical and Experimental Rheumatology,2001.197-200.
-
5Lauchli S,Trüeb RM,Fehr M. Scleroderma-like drug reaction to paclitaxel (Taxol)[J].{H}British Journal of Dermatology,2002.619-621.
-
6De Angelis R,Bugatti L,Cerioni A. Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer[J].{H}CLINICAL RHEUMATOLOGY,2003.49-52.
-
7Kupfer I,Balguerie X,Courville P. Scleroderma-like cutaneous lesions induced by paclitaxel:a case study[J].{H}Journal of The American Academy of Dermatology,2003.279-281.
-
8Battafarano DF,Zimmerman GC,Older SA. Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities.A report of three cases[J].{H}CANCER,1995.110-115.
-
9Cleveland MG,Ajaikumar BS,Reganti R. Cutaneous fibrosis induced by docetaxel:a case report[J].{H}CANCER,2000.1078-1081.
-
1银联飞,韦婷婷,黄容容,杨璨瑜,苏盈,韦山,沈让,宾晓芸.紫杉醇诱导大鼠神经病理性疼痛模型的建立[J].右江民族医学院学报,2015,37(3):357-359. 被引量:5
-
2王君.阿尔茨海默病系统评估的探讨[J].山西医药杂志(上半月),2009,38(4):366-367.
-
3孙曙光,李才锐.葛根素注射液治疗脑梗死的临床观察[J].中国当代医药,2009,16(12):35-36. 被引量:3
-
4陈韫炜.黄芪桂枝五物汤加味治疗多发性硬化30例[J].湖南中医杂志,2006,22(5):50-50. 被引量:10
-
5代亚锋,王卫卫,段秋宁.系统性硬化病误诊为心肌梗死[J].临床误诊误治,2005,18(12):933-934.
-
6刘秀广.急性脑血管病并发应激性溃疡临床资料分析[J].实用医药杂志,2009,26(7):36-37. 被引量:5
-
7吴建伟,黄成龙,华春珍,李珊.系统性硬化症731例分析[J].浙江预防医学,2008,20(7):80-81. 被引量:4
-
8陈连香,肖镇,黄彬涛,王威.神经元特异性烯醇化酶在弥漫大B细胞淋巴瘤缓解患者血清中的表达及其意义[J].白血病.淋巴瘤,2014,23(2):103-106. 被引量:3
-
9刘润荣,李梦涛,徐东,侯勇,王迁,胡朝军,宋宁,张奉春,赵岩,曾小峰.抗U1核糖核蛋白抗体在系统性硬化症诊治中的临床意义[J].中华全科医师杂志,2011,10(5):315-319. 被引量:4
-
10张凤英,吴华香,何虹,陈淑芳.重症系统性硬化症合并口腔颌面部等病症[J].中华急诊医学杂志,2009,18(11):1218-1220.